Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Gains from Sales and Divestitures (2020)

Selectis Health's Gains from Sales and Divestitures history spans 1 years, with the latest figure at $7500.0 for Q4 2020.

  • For Q4 2020, Gains from Sales and Divestitures changed N/A year-over-year to $7500.0; the TTM value through Dec 2020 reached $7500.0, changed N/A, while the annual FY2020 figure was $7500.0, N/A changed from the prior year.
  • Gains from Sales and Divestitures for Q4 2020 was $7500.0 at Selectis Health.
  • Across five years, Gains from Sales and Divestitures topped out at $7500.0 in Q4 2020 and bottomed at $7500.0 in Q4 2020.